非索非那定 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "非索非那定" in Chinese language version.

refsWebsite

Global rank Chinese rank

18nih.gov

4^th place

5^th place

14doi.org

2^nd place

23^rd place

4web.archive.org

1^st place

4archive.org

6^th place

4^th place

3medicines.org.uk

3,823^rd place

3,456^th place

2drugs.com

399^th place

208^th place

2semanticscholar.org

11^th place

332^nd place

2clincalc.com

3,912^th place

5,917^th place

1sanofi.ca

low place

1books.google.com

3^rd place

8^th place

1handle.net

102^nd place

492^nd place

1drreddys.com

low place

1allegra.com

low place

1gov.uk

432^nd place

770^th place

1medicinesinpregnancy.org

low place

1nhs.uk

1,989^th place

2,409^th place

allegra.com (Global: low place; Chinese: low place)

Allegra FAQs. Sanofi-Aventis. [2011-07-05]. （原始内容存档于2011-05-20）.

archive.org (Global: 6^th place; Chinese: 4^th place)

Dicpinigaitis PV, Gayle YE. Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function. British Journal of Clinical Pharmacology. November 2003, 56 (5): 501–504. PMC 1884387 . PMID 14651723. doi:10.1046/j.1365-2125.2003.01902.x.
Hampel F, Ratner P, Mansfield L, Meeves S, Liao Y, Georges G. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology. October 2003, 91 (4): 354–361. PMID 14582814. doi:10.1016/S1081-1206(10)61682-1.
Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. The Journal of Allergy and Clinical Immunology. November 1999, 104 (5): 927–933. PMID 10550734. doi:10.1016/s0091-6749(99)70070-9 .
Stoltz M, Arumugham T, Lippert C, Yu D, Bhargava V, Eller M, Weir S. Effect of food on the bioavailability of fexofenadine hydrochloride (MDL 16455A). Biopharmaceutics & Drug Disposition. October 1997, 18 (7): 645–648. PMID 9330784. doi:10.1002/(SICI)1099-081X(199710)18:7<645::AID-BDD50>3.0.CO;2-3.

books.google.com (Global: 3^rd place; Chinese: 8^th place)

Fischer J, Ganellin CR. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 548. ISBN 9783527607495.

clincalc.com (Global: 3,912^th place; Chinese: 5,917^th place)

The Top 300 of 2022. ClinCalc. [2024-03-30]. （原始内容存档于30 August 2024）.
Fexofenadine Drug Usage Statistics, United States, 2013 - 2022. ClinCalc. [2024-08-30].

doi.org (Global: 2^nd place; Chinese: 23^rd place)

Lappin G, Shishikura Y, Jochemsen R, Weaver RJ, Gesson C, Houston B, Oosterhuis B, Bjerrum OJ, Rowland M, Garner C. Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability. European Journal of Pharmaceutical Sciences. May 2010, 40 (2): 125–131. PMID 20307657. doi:10.1016/j.ejps.2010.03.009.
fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders. Expert Opinion on Drug Metabolism & Toxicology. July 2009, 5 (7): 813–822. PMID 19545214. S2CID 19048690. doi:10.1517/17425250903044967. 已忽略文本“ vauthors 周邊選擇性藥物 Smith SM, Gums JG ” (帮助)
Bachert C. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Clinical Therapeutics. May 2009, 31 (5): 921–944. PMID 19539095. doi:10.1016/j.clinthera.2009.05.017.
Compalati E, Baena-Cagnani R, Penagos M, Badellino H, Braido F, Gómez RM, Canonica GW, Baena-Cagnani CE. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. International Archives of Allergy and Immunology. 2011, 156 (1): 1–15. PMID 21969990. doi:10.1159/000321896 .
Dicpinigaitis PV, Gayle YE. Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function. British Journal of Clinical Pharmacology. November 2003, 56 (5): 501–504. PMC 1884387 . PMID 14651723. doi:10.1046/j.1365-2125.2003.01902.x.
Welzel T, Ziesenitz VC, Seitz S, Donner B, van den Anker JN. Management of anaphylaxis and allergies in patients with long QT syndrome: A review of the current evidence. Annals of Allergy, Asthma & Immunology. November 2018, 121 (5): 545–551. PMID 30059791. doi:10.1016/j.anai.2018.07.027 .
Hampel F, Ratner P, Mansfield L, Meeves S, Liao Y, Georges G. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology. October 2003, 91 (4): 354–361. PMID 14582814. doi:10.1016/S1081-1206(10)61682-1.
Grant JA, Riethuisen JM, Moulaert B, DeVos C. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Annals of Allergy, Asthma & Immunology. February 2002, 88 (2): 190–197. PMID 11868924. doi:10.1016/S1081-1206(10)61995-3.
Casale TB, Andrade C, Qu R. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis. Allergy and Asthma Proceedings. 1999, 20 (3): 193–198. PMID 10389553. doi:10.2500/108854199778553046.
Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. The Journal of Allergy and Clinical Immunology. November 1999, 104 (5): 927–933. PMID 10550734. doi:10.1016/s0091-6749(99)70070-9 .
Philpot EE. Safety of second-generation antihistamines. Allergy and Asthma Proceedings. Jan–Feb 2000, 21 (1): 15–20. PMID 10748947. doi:10.2500/108854100778249033.
Stoltz M, Arumugham T, Lippert C, Yu D, Bhargava V, Eller M, Weir S. Effect of food on the bioavailability of fexofenadine hydrochloride (MDL 16455A). Biopharmaceutics & Drug Disposition. October 1997, 18 (7): 645–648. PMID 9330784. doi:10.1002/(SICI)1099-081X(199710)18:7<645::AID-BDD50>3.0.CO;2-3.
Shirasaka Y, Mori T, Murata Y, Nakanishi T, Tamai I. Substrate- and dose-dependent drug interactions with grapefruit juice caused by multiple binding sites on OATP2B1. Pharmaceutical Research. August 2014, 31 (8): 2035–2043. PMID 24549825. S2CID 17532347. doi:10.1007/s11095-014-1305-7.
Shehnaz H, Haider A, Arayne MS, Sultana N. Carboxyterfenadine antacid interaction monitoring by UV spectrophotometry and RP-HPLC techniques. Arabian Journal of Chemistry. Nov 2014, 7 (5): 839–845. doi:10.1016/j.arabjc.2013.01.011 .

drreddys.com (Global: low place; Chinese: low place)

Dr. Reddy's announces the launch of Over-the-Counter Fexofenadine HCl and Pseudoephedrine HCl extended-release tablets. Dr. Reddy's Laboratories Ltd. 30 August 2011 [27 May 2016]. （原始内容存档于12 October 2016）.

drugs.com (Global: 399^th place; Chinese: 208^th place)

fexofenadine Use During Pregnancy. Drugs.com. 2019-04-01 [2020-07-26].
Fexofenadine - international brand names. Drugs.com. [2017-01-18].

gov.uk (Global: 432^nd place; Chinese: 770^th place)

PAR: Reclassification of Allevia 120mg tablets from Prescription Only Medicine (POM) to General Sales List (GSL). MHRA. 2020-12-22.

handle.net (Global: 102^nd place; Chinese: 492^nd place)

hdl.handle.net

World Health Organization. World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. 2021. hdl:10665/345533 . WHO/MHP/HPS/EML/2021.02.

medicines.org.uk (Global: 3,823^rd place; Chinese: 3,456^th place)

Telfast 30mg Film-coated Tablets - Summary of Product Characteristics (SmPC). (emc). 2019 -10-25 [2021-06-20]. 请检查|date=中的日期值 (帮助)
Almerg 180 mg Film-Coated Tablets - Summary of Product Characteristics (SmPC). (emc). [2021-06-20].
fexofenadine Hydrochloride 120 mg Film-Coated Tablets - Summary of Product Characteristics (SmPC). (emc). 2021-03-22 [2021-06-20]. （原始内容存档于2021-06-24）.

medicinesinpregnancy.org (Global: low place; Chinese: low place)

https://www.medicinesinpregnancy.org/leaflets-a-z/fexofenadine-/#:~:text=Search%20medicines-,Fexofenadine,-Print. Bumps. November 2018 [2024-12-26-]. 外部链接存在于|title= (帮助)

nhs.uk (Global: 1,989^th place; Chinese: 2,409^th place)

. NHS https://www.nhs.uk/medicines/fexofenadine/. [2024-12-26-]. 缺少或|title=为空 (帮助)

nih.gov (Global: 4^th place; Chinese: 5^th place)

ncbi.nlm.nih.gov

Lappin G, Shishikura Y, Jochemsen R, Weaver RJ, Gesson C, Houston B, Oosterhuis B, Bjerrum OJ, Rowland M, Garner C. Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability. European Journal of Pharmaceutical Sciences. May 2010, 40 (2): 125–131. PMID 20307657. doi:10.1016/j.ejps.2010.03.009.
fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders. Expert Opinion on Drug Metabolism & Toxicology. July 2009, 5 (7): 813–822. PMID 19545214. S2CID 19048690. doi:10.1517/17425250903044967. 已忽略文本“ vauthors 周邊選擇性藥物 Smith SM, Gums JG ” (帮助)
Bachert C. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Clinical Therapeutics. May 2009, 31 (5): 921–944. PMID 19539095. doi:10.1016/j.clinthera.2009.05.017.
Compalati E, Baena-Cagnani R, Penagos M, Badellino H, Braido F, Gómez RM, Canonica GW, Baena-Cagnani CE. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. International Archives of Allergy and Immunology. 2011, 156 (1): 1–15. PMID 21969990. doi:10.1159/000321896 .
Dicpinigaitis PV, Gayle YE. Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function. British Journal of Clinical Pharmacology. November 2003, 56 (5): 501–504. PMC 1884387 . PMID 14651723. doi:10.1046/j.1365-2125.2003.01902.x.
Welzel T, Ziesenitz VC, Seitz S, Donner B, van den Anker JN. Management of anaphylaxis and allergies in patients with long QT syndrome: A review of the current evidence. Annals of Allergy, Asthma & Immunology. November 2018, 121 (5): 545–551. PMID 30059791. doi:10.1016/j.anai.2018.07.027 .
Hampel F, Ratner P, Mansfield L, Meeves S, Liao Y, Georges G. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology. October 2003, 91 (4): 354–361. PMID 14582814. doi:10.1016/S1081-1206(10)61682-1.
Kruszewski J, Kłos K, Sułek K. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial]. Polski Merkuriusz Lekarski. November 2006, 21 (125): 443–448. PMID 17345837.
Grant JA, Riethuisen JM, Moulaert B, DeVos C. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Annals of Allergy, Asthma & Immunology. February 2002, 88 (2): 190–197. PMID 11868924. doi:10.1016/S1081-1206(10)61995-3.
Casale TB, Andrade C, Qu R. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis. Allergy and Asthma Proceedings. 1999, 20 (3): 193–198. PMID 10389553. doi:10.2500/108854199778553046.
Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. The Journal of Allergy and Clinical Immunology. November 1999, 104 (5): 927–933. PMID 10550734. doi:10.1016/s0091-6749(99)70070-9 .
Philpot EE. Safety of second-generation antihistamines. Allergy and Asthma Proceedings. Jan–Feb 2000, 21 (1): 15–20. PMID 10748947. doi:10.2500/108854100778249033.
Stoltz M, Arumugham T, Lippert C, Yu D, Bhargava V, Eller M, Weir S. Effect of food on the bioavailability of fexofenadine hydrochloride (MDL 16455A). Biopharmaceutics & Drug Disposition. October 1997, 18 (7): 645–648. PMID 9330784. doi:10.1002/(SICI)1099-081X(199710)18:7<645::AID-BDD50>3.0.CO;2-3.
Shirasaka Y, Mori T, Murata Y, Nakanishi T, Tamai I. Substrate- and dose-dependent drug interactions with grapefruit juice caused by multiple binding sites on OATP2B1. Pharmaceutical Research. August 2014, 31 (8): 2035–2043. PMID 24549825. S2CID 17532347. doi:10.1007/s11095-014-1305-7.

dailymed.nlm.nih.gov

Allegra (fexofenadine hydrochloride) tablet, orally disintegrating for oral use Allegra (fexofenadine hydrochloride) tablet, film coated for oral use Allegra (fexofenadine hydrochloride) suspension for oral useInitial U.S. Approval: 1996. DailyMed. 2008-12-15 [2022-02-13].
Allegra Allergy- fexofenadine hydrochloride tablet, coated. DailyMed. [2022-02-12].

pubmed.ncbi.nlm.nih.gov

Kruszewski J, Kłos K, Sułek K. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial]. Polski Merkuriusz Lekarski. November 2006, 21 (125): 443–448. PMID 17345837.

pmc.ncbi.nlm.nih.gov

Tannergren, Christer; Knutson, Tina. The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique. British Journal of Clinical Pharmacology. February 2003, 55 (2): 182–190 [2024-12-26].

sanofi.ca (Global: low place; Chinese: low place)

products.sanofi.ca

ALLEGRA (fexofenadine hydrochloride) Product Monograph (PDF). Sanofi Consumer Health Inc. 2019-11-07.

semanticscholar.org (Global: 11^th place; Chinese: 332^nd place)

api.semanticscholar.org

fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders. Expert Opinion on Drug Metabolism & Toxicology. July 2009, 5 (7): 813–822. PMID 19545214. S2CID 19048690. doi:10.1517/17425250903044967. 已忽略文本“ vauthors 周邊選擇性藥物 Smith SM, Gums JG ” (帮助)
Shirasaka Y, Mori T, Murata Y, Nakanishi T, Tamai I. Substrate- and dose-dependent drug interactions with grapefruit juice caused by multiple binding sites on OATP2B1. Pharmaceutical Research. August 2014, 31 (8): 2035–2043. PMID 24549825. S2CID 17532347. doi:10.1007/s11095-014-1305-7.

web.archive.org (Global: 1^st place; Chinese: 1^st place)

fexofenadine Hydrochloride 120 mg Film-Coated Tablets - Summary of Product Characteristics (SmPC). (emc). 2021-03-22 [2021-06-20]. （原始内容存档于2021-06-24）.
Dr. Reddy's announces the launch of Over-the-Counter Fexofenadine HCl and Pseudoephedrine HCl extended-release tablets. Dr. Reddy's Laboratories Ltd. 30 August 2011 [27 May 2016]. （原始内容存档于12 October 2016）.
Allegra FAQs. Sanofi-Aventis. [2011-07-05]. （原始内容存档于2011-05-20）.
The Top 300 of 2022. ClinCalc. [2024-03-30]. （原始内容存档于30 August 2024）.

非索非那定 (Chinese Wikipedia)

allegra.com (Global: low place; Chinese: low place)

archive.org (Global: 6th place; Chinese: 4th place)

books.google.com (Global: 3rd place; Chinese: 8th place)

clincalc.com (Global: 3,912th place; Chinese: 5,917th place)

doi.org (Global: 2nd place; Chinese: 23rd place)

drreddys.com (Global: low place; Chinese: low place)

drugs.com (Global: 399th place; Chinese: 208th place)

gov.uk (Global: 432nd place; Chinese: 770th place)

handle.net (Global: 102nd place; Chinese: 492nd place)

hdl.handle.net

medicines.org.uk (Global: 3,823rd place; Chinese: 3,456th place)

medicinesinpregnancy.org (Global: low place; Chinese: low place)

nhs.uk (Global: 1,989th place; Chinese: 2,409th place)

nih.gov (Global: 4th place; Chinese: 5th place)

ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

sanofi.ca (Global: low place; Chinese: low place)

products.sanofi.ca

semanticscholar.org (Global: 11th place; Chinese: 332nd place)

api.semanticscholar.org

web.archive.org (Global: 1st place; Chinese: 1st place)

archive.org (Global: 6^th place; Chinese: 4^th place)

books.google.com (Global: 3^rd place; Chinese: 8^th place)

clincalc.com (Global: 3,912^th place; Chinese: 5,917^th place)

doi.org (Global: 2^nd place; Chinese: 23^rd place)

drugs.com (Global: 399^th place; Chinese: 208^th place)

gov.uk (Global: 432^nd place; Chinese: 770^th place)

handle.net (Global: 102^nd place; Chinese: 492^nd place)

medicines.org.uk (Global: 3,823^rd place; Chinese: 3,456^th place)

nhs.uk (Global: 1,989^th place; Chinese: 2,409^th place)

nih.gov (Global: 4^th place; Chinese: 5^th place)

semanticscholar.org (Global: 11^th place; Chinese: 332^nd place)

web.archive.org (Global: 1^st place; Chinese: 1^st place)